top of page
Bexarotene

貝沙羅汀
Mechanism of action:
Bexarotene 是一種選擇性類視黃醇 X 受體(retinoid X receptor,RXR)促效劑。Bexarotene 會活化細胞核內的受體 RXR(相對上較偏向 RXR 路徑而非 RAR),進而調控多種與細胞分化、增殖及凋亡相關的基因表達,影響腫瘤細胞增殖,並可促進細胞分化與凋亡,並可降低 IL-2、IL-4、IFN-γ 等發炎性細胞激素的表達。
Reference(s):
1. Gniadecki R et al. (2007). The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol.
2. Dragnev KH et al. (2007). A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clin Cancer Res.
bottom of page
